ABC-06 Trial – Information update

Discussion Forum Discussion Forum Clinical Trials and Treatments ABC-06 Trial – Information update

This topic contains 0 replies, has 1 voice, and was last updated by  Helen_ammf 2 years, 6 months ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #9559

    Helen_ammf
    Moderator

    ABC-06 is a 2nd line chemotherapy trial, suitable for those who have had already had the Gemcitabine/Cisplatin chemotherapy, or who now have metastatic disease.

    However, this is a randomized trial with two arms –

    Active Symptom Control with ‘OxMdG’ chemotherapy (Oxaliplatin, L-folinic acid & 5FU)

    – against –

    Active Symptom Control

    AMMF has been informed this week (26.09.16) that patients taking part in either arm of this trial may also participate in relevant Phase I trials, if eligible.

    So if the decision is made to go for ABC-06, but you are randomised to the Active Symptom Control arm you can be considered for any suitable Phase I trial straight away*.

    For those randomised to the chemotherapy arm, at least 28 days after their last chemotherapy treatment should be allowed before starting a Phase I trial.

    For more information about this, and contact details, see:

    https://ammf.org.uk/clinical-trials/

    *This should always be done in consultation with the ABC-06 trial office.

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.